Clinical Research Directory
Browse clinical research sites, groups, and studies.
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
Sponsor: Elephas
Summary
This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a normal course of their medical management or diagnostic work-up for suspected or confirmed cancer.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2025-04-14
Completion Date
2038-04
Last Updated
2026-01-08
Healthy Volunteers
No
Conditions
Interventions
Biopsy
Subjects must be clinically able, at investigator discretion, to undergo additional biopsy passes during their biopsy. Biopsy specimen(s) will be obtained during a standard of care (SOC) procedure. If a subject receives a subsequent SOC biopsy for clinical diagnosis purposes, additional sample(s) may be collected and sent to the Sponsor.
Locations (8)
Mercy Hospital - FTS
Fort Smith, Arkansas, United States
Frederick Health Hospital
Frederick, Maryland, United States
Mercy Hospital - SPG
Springfield, Missouri, United States
Mercy Hospital - South
St Louis, Missouri, United States
Mercy Hospital -STL
St Louis, Missouri, United States
Mercy Hospital - OKC
Oklahoma City, Oklahoma, United States
JPS Health Network
Forth Worth, Texas, United States
Baylor Scott and White Biorepository
Temple, Texas, United States